Logo image of CAMT

CAMTEK LTD (CAMT) Stock Fundamental Analysis

NASDAQ:CAMT - Nasdaq - IL0010952641 - Common Stock - Currency: USD

58.62  -1.75 (-2.9%)

After market: 58.62 0 (0%)

Fundamental Rating

5

Overall CAMT gets a fundamental rating of 5 out of 10. We evaluated CAMT against 109 industry peers in the Semiconductors & Semiconductor Equipment industry. While CAMT has a great profitability rating, there are some minor concerns on its financial health. CAMT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

CAMT had positive earnings in the past year.
Of the past 5 years CAMT 4 years were profitable.
CAMT had a positive operating cash flow in 4 of the past 5 years.
CAMT Yearly Net Income VS EBIT VS OCF VS FCFCAMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M

1.2 Ratios

CAMT's Return On Assets of 12.63% is amongst the best of the industry. CAMT outperforms 81.65% of its industry peers.
With an excellent Return On Equity value of 20.69%, CAMT belongs to the best of the industry, outperforming 87.16% of the companies in the same industry.
CAMT has a Return On Invested Capital of 11.87%. This is amongst the best in the industry. CAMT outperforms 82.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CAMT is in line with the industry average of 11.16%.
The 3 year average ROIC (11.38%) for CAMT is below the current ROIC(11.87%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.63%
ROE 20.69%
ROIC 11.87%
ROA(3y)10.71%
ROA(5y)10.52%
ROE(3y)19.29%
ROE(5y)16.71%
ROIC(3y)11.38%
ROIC(5y)11.46%
CAMT Yearly ROA, ROE, ROICCAMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

CAMT's Profit Margin of 26.53% is amongst the best of the industry. CAMT outperforms 88.07% of its industry peers.
In the last couple of years the Profit Margin of CAMT has grown nicely.
With an excellent Operating Margin value of 23.91%, CAMT belongs to the best of the industry, outperforming 83.49% of the companies in the same industry.
In the last couple of years the Operating Margin of CAMT has grown nicely.
The Gross Margin of CAMT (47.80%) is better than 61.47% of its industry peers.
CAMT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.91%
PM (TTM) 26.53%
GM 47.8%
OM growth 3Y13.43%
OM growth 5Y5.43%
PM growth 3Y21.29%
PM growth 5Y10.39%
GM growth 3Y-0.12%
GM growth 5Y-1.05%
CAMT Yearly Profit, Operating, Gross MarginsCAMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CAMT is destroying value.
There is no outstanding debt for CAMT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CAMT Yearly Shares OutstandingCAMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CAMT Yearly Total Debt VS Total AssetsCAMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

CAMT has an Altman-Z score of 7.09. This indicates that CAMT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CAMT (7.09) is better than 75.23% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that CAMT is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.38, CAMT is not doing good in the industry: 66.06% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Altman-Z 7.09
ROIC/WACC1
WACC11.92%
CAMT Yearly LT Debt VS Equity VS FCFCAMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

CAMT has a Current Ratio of 5.28. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
CAMT has a Current ratio of 5.28. This is in the better half of the industry: CAMT outperforms 77.98% of its industry peers.
A Quick Ratio of 4.36 indicates that CAMT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.36, CAMT is in the better half of the industry, outperforming 79.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.28
Quick Ratio 4.36
CAMT Yearly Current Assets VS Current LiabilitesCAMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 44.10% over the past year.
The Earnings Per Share has been growing by 34.86% on average over the past years. This is a very strong growth
EPS 1Y (TTM)44.1%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%35.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%32.25%

3.2 Future

Based on estimates for the next years, CAMT will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.43% on average per year.
CAMT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.44% yearly.
EPS Next Y15.59%
EPS Next 2Y13.02%
EPS Next 3Y7.89%
EPS Next 5Y12.43%
Revenue Next Year16.15%
Revenue Next 2Y12.19%
Revenue Next 3Y8.72%
Revenue Next 5Y11.44%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CAMT Yearly Revenue VS EstimatesCAMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 200M 400M 600M
CAMT Yearly EPS VS EstimatesCAMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 1 2 3 4 5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.86, which indicates a rather expensive current valuation of CAMT.
Compared to the rest of the industry, the Price/Earnings ratio of CAMT indicates a somewhat cheap valuation: CAMT is cheaper than 70.64% of the companies listed in the same industry.
CAMT is valuated rather cheaply when we compare the Price/Earnings ratio to 27.63, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 18.05 indicates a rather expensive valuation of CAMT.
CAMT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CAMT is cheaper than 73.39% of the companies in the same industry.
CAMT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.85.
Industry RankSector Rank
PE 20.86
Fwd PE 18.05
CAMT Price Earnings VS Forward Price EarningsCAMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CAMT.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 22.15
CAMT Per share dataCAMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CAMT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.34
PEG (5Y)0.6
EPS Next 2Y13.02%
EPS Next 3Y7.89%

More info and screens

0

5. Dividend

5.1 Amount

CAMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CAMTEK LTD

NASDAQ:CAMT (4/21/2025, 8:00:02 PM)

After market: 58.62 0 (0%)

58.62

-1.75 (-2.9%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-12 2025-02-12/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners50.42%
Inst Owner Change0.07%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap2.67B
Analysts84
Price Target112.2 (91.4%)
Short Float %15.43%
Short Ratio7.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.39%
Min EPS beat(2)0.71%
Max EPS beat(2)6.06%
EPS beat(4)4
Avg EPS beat(4)5.42%
Min EPS beat(4)0.71%
Max EPS beat(4)8.76%
EPS beat(8)7
Avg EPS beat(8)3.56%
EPS beat(12)9
Avg EPS beat(12)2.39%
EPS beat(16)13
Avg EPS beat(16)4.4%
Revenue beat(2)1
Avg Revenue beat(2)0.33%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)0.25%
Min Revenue beat(4)-1.23%
Max Revenue beat(4)1.57%
Revenue beat(8)2
Avg Revenue beat(8)-0.38%
Revenue beat(12)3
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)0.45%
PT rev (1m)0%
PT rev (3m)1.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.39%
EPS NY rev (1m)0%
EPS NY rev (3m)0.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE 20.86
Fwd PE 18.05
P/S 6.67
P/FCF N/A
P/OCF N/A
P/B 5.2
P/tB 6.28
EV/EBITDA 22.15
EPS(TTM)2.81
EY4.79%
EPS(NY)3.25
Fwd EY5.54%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.79
BVpS11.27
TBVpS9.33
PEG (NY)1.34
PEG (5Y)0.6
Profitability
Industry RankSector Rank
ROA 12.63%
ROE 20.69%
ROCE 13.16%
ROIC 11.87%
ROICexc 26.31%
ROICexgc 36.04%
OM 23.91%
PM (TTM) 26.53%
GM 47.8%
FCFM N/A
ROA(3y)10.71%
ROA(5y)10.52%
ROE(3y)19.29%
ROE(5y)16.71%
ROIC(3y)11.38%
ROIC(5y)11.46%
ROICexc(3y)41.1%
ROICexc(5y)40.46%
ROICexgc(3y)43.5%
ROICexgc(5y)42.07%
ROCE(3y)12.62%
ROCE(5y)12.7%
ROICexcg growth 3Y-14.44%
ROICexcg growth 5Y-8.43%
ROICexc growth 3Y-22.7%
ROICexc growth 5Y-13.87%
OM growth 3Y13.43%
OM growth 5Y5.43%
PM growth 3Y21.29%
PM growth 5Y10.39%
GM growth 3Y-0.12%
GM growth 5Y-1.05%
F-ScoreN/A
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF N/A
Debt/EBITDA 1.95
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.28
Quick Ratio 4.36
Altman-Z 7.09
F-ScoreN/A
WACC11.92%
ROIC/WACC1
Cap/Depr(3y)164.71%
Cap/Depr(5y)135.1%
Cap/Sales(3y)2.25%
Cap/Sales(5y)1.89%
Profit Quality(3y)82.16%
Profit Quality(5y)91.7%
High Growth Momentum
Growth
EPS 1Y (TTM)44.1%
EPS 3Y20.9%
EPS 5Y34.86%
EPS Q2Q%35.09%
EPS Next Y15.59%
EPS Next 2Y13.02%
EPS Next 3Y7.89%
EPS Next 5Y12.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%32.25%
Revenue Next Year16.15%
Revenue Next 2Y12.19%
Revenue Next 3Y8.72%
Revenue Next 5Y11.44%
EBIT growth 1Y39.52%
EBIT growth 3Y43.47%
EBIT growth 5Y27.24%
EBIT Next Year68.24%
EBIT Next 3Y32.55%
EBIT Next 5YN/A
FCF growth 1Y43.53%
FCF growth 3Y45.38%
FCF growth 5Y37.5%
OCF growth 1Y37.24%
OCF growth 3Y45.5%
OCF growth 5Y36.42%